Because the children of today all deserve a tomorrow

Leukaemia

Leukaemia is the most common type of childhood cancer, accounting for nearly a third of all cancers in children. It is a cancer of the white blood cells. White blood cells are usually involved in fighting infection. Each year in the UK, around 520 children and another 200 young people are diagnosed with leukaemia.

There are two different types of white blood cells – lymphoid cells (lymphocytes) and myeloid cells. Normally, white blood cells are produced in the bone marrow and then they repair and reproduce themselves in an orderly and controlled way. When a child has leukaemia, this process gets out of control and the cells continue to divide, but they do not mature as they should.

Symptoms of leukaemia

Some children with leukaemia have a number of symptoms at diagnosis, but others can have relatively few.  These symptoms may include:

  • Persistent tiredness or looking very pale (pallor)
  • Bone pain
  • Unexplained fevers and infections
  • Night sweats
  • Weight loss
  • Unexplained bruising, unusual rashes
  • Excess bleeding, for example nose bleeds

Acute lymphoblastic leukaemia

Acute lymphoblastic leukaemia (ALL) occurs when an immature type of white blood cell (lymphoblasts) take over the bone marrow stopping normal cells from functioning.

The two main subtypes are:

  • B-cell (87% of cases)
  • T-Cell (13% of cases)

ALL accounts for almost 80% of all childhood leukaemias with around 400 new cases every year in the UK.

It most commonly develops between 2 and 3 years of age and is slightly more common in boys than girls.

Treatment is usually divided into three main parts:

  1. Induction: the treatment phase when most of the leukaemia cells are destroyed
  2. Consolidation (intensification): further blocks of treatment to eradicate any remaining disease (minimum residual disease)
  3. Maintenance therapy: this is an extended block of treatment to help prevent cancer from returning (relapse).

The total treatment duration for girls is 2 to 2.5 years, and for boys it is usually 3 years. This is because on average boys and girls respond in slightly different ways to treatment.

Acute myeloid leukaemia

Acute myeloid leukaemia (AML) is caused by an overproduction of myeloblasts (a type of white blood cell) and accounts for 15% of childhood leukaemia.

Around 70 children are diagnosed with AML every year in the UK. The treatment for AML is shorter and more intensive than for ALL with the total duration of treatment being around 6 months. Children will usually be admitted to hospital for the full duration of their treatment.

A high proportion of children with AML will achieve remission but unfortunately, up to a quarter of these children will relapse (usually in the three years following treatment) so children with AML will be monitored closely after treatment ends.

Chronic myeloid leukaemia (CML)

CML is very rare in children, but if it occurs, it is treated using a stem cell transplant.

If you are reading this page

If you are reading this page, the likelihood is that you are concerned that your child or a child you know may have cancer. Alternatively, you may have a child that has recently been diagnosed with cancer. 

You can find out more on the links below, but if you have any concerns or queries, please ensure that your child is reviewed by a doctor.

Page last reviewed October 2026. Review next due October 2029.

Search